Vulcan Value Partners recent buys & sells (2014 Q2)
C.T. Fitzpatrick
Vulcan Value Partners Portfolio Changes
Purchase & sale details
- Portfolio value:
- $6.76B (+$1B)
- Previous value:
- $5.65B
- # of changes:
- 107
- New positions:
- 46
- Reported for:
- 30 Jun 2014 (Q2)
- Latest filing date:
- 13 Aug 2014
Vulcan Value Partners has disclosed a total of 107 changes to the portfolio in the (2014 Q2) SEC report(s): increased the number of shares of 39, bought 46 totally new, decreased the number of shares of 17 and completely sold out 5 position(s).
What stocks did Vulcan Value Partners buy in 2014 Q2?
During 2014 Q2 Vulcan Value Partners has bought 85 securities out of which top 5 purchases (by % change to portfolio) were (NDAQ) Nasdaq Inc (added shares +44.23%), (DISCK) Discovery Inc (added shares +101.73%), (V) Visa Inc, CL-A (added shares +92.90%), (EBAY) eBay Inc (added shares +40.13%) and (BEN) Franklin Resources Inc (added shares +3.96%).
In the 2014 Q2 report(s) the following changes have been made to the top investments: (ORCL) Oracle Corp (reduced shares -9.49%), (NDAQ) Nasdaq Inc (added shares +44.23%), (DISCK) Discovery Inc (added shares +101.73%), (AAPL) Apple Inc (reduced shares -24.83%) and (V) Visa Inc, CL-A (added shares +92.90%).
107 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AbbVie Inc
|
new
|
$56.05
|
+406.68%($284.00)
|
0.00%
|
2014 Q2
|
~0.25 years
|
||||
|
|
Abbott Laboratories
|
new
|
$40.76
|
+155.14%($104.00)
|
0.00%
|
2014 Q2
|
~0.25 years
|
||||
|
|
American Eagle Outfitters Inc
|
new
|
$11.24
|
+58.06%($17.77)
|
0.00%
|
2014 Q2
|
~0.25 years
|
||||
|
|
Aetna Inc
|
new
|
$81.08
|
|
1.47%
|
2014 Q2
|
~0.25 years
|
||||
|
|
Align Technology Inc
|
new
|
$57.69
|
+159.25%($149.57)
|
0.00%
|
2014 Q2
|
~0.25 years
|
||||
|
|
ALLOT LTD
|
new
|
$12.50
|
-27.60%($9.05)
|
0.00%
|
2014 Q2
|
~0.25 years
|
||||
|
|
Avista Corp
|
new
|
$33.44
|
+8.29%($36.22)
|
0.00%
|
2014 Q2
|
~0.25 years
|
||||
|
|
Becton Dickinson and Company
|
new
|
$117.65
|
+62.74%($191.46)
|
0.00%
|
2014 Q2
|
~0.25 years
|
||||
|
|
Bank of Montreal
|
new
|
$73.39
|
+126.01%($165.88)
|
0.00%
|
2014 Q2
|
~0.25 years
|
||||
|
|
Celgene Corp
|
new
|
$87.80
|
|
0.00%
|
2014 Q2
|
~0.25 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".